Diagnostic value of plasma antidiuretic hormone, electrocochleography, and glycerol test in patients with endolymphatic hydrops

ORL

Volumn 71, Issue SUPPL. 1, 2010, Pages 26-29

  Taguchi, Daizo ^a,b   Kakigi, Akinobu ^b,c   Takeda, Taizo ^b   Sawada, Shoichi ^b   Nakatani, Hiroaki ^b  

^a TOTTORI UNIVERSITY   (Japan)

^b KOCHI MEDICAL SCHOOL   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

Author keywords

Antidiuretic hormone; Electrocochleogram; Endolymphatic hydrops diseases; Glycerol test; M ni re's disease

Indexed keywords

GLYCEROL; VASOPRESSIN;

ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; ELECTROCOCHLEOGRAPHY; HUMAN; MAJOR CLINICAL STUDY; MEASUREMENT; MENIERE DISEASE; PRIORITY JOURNAL; TIME; VASOPRESSIN BLOOD LEVEL;

AUDIOMETRY, EVOKED RESPONSE; CHI-SQUARE DISTRIBUTION; ENDOLYMPHATIC HYDROPS; GLYCEROL; HUMANS; LINEAR MODELS; VASOPRESSINS;

EID: 77952563173     PISSN: 03011569     EISSN: None     Source Type: Journal    
DOI: 10.1159/000265117     Document Type: Article

References (17)

1. Nakashima T, Naganawa S, Sugiura M, Teranishi M, Sone M, Hayashi H, Nakata S, Katayama N, Ishida IM: Visualization of endolymphatic hydrops in patients with Ménière's disease. Laryngoscope 2007; 117: 415-420.
2. Ferraro JA, Durrant JD: Electrocochleography in the evaluation of patients with Ménière's disease/endolymphatic hydrops. J Am Acad Audiol 2006; 17: 45-68.
3. Orchik DJ, Shea JJ Jr, Ge X: Transtympanic electrocochleography in Ménière's disease using clicks and tone-bursts. Am J Otol 1993; 14: 290-294.
4. Stahle J: Medical treatment of fluctuant hearing loss in Ménière's disease. Am J Otol 1984; 5: 529-533.
5. Takeda T, Kakigi A, Saito H: Antidiuretic hormone and endolymphatic hydrops. Acta Otolaryngol Suppl (Stockh) 1995; 519: 219-222.
6. Takeda T, Takeda S, Kitano H, Okada T, Kakigi A: Endolymphatic hydrops induced by chronic administration of vasopressin. Hear Res 2000; 140: 1-6.
7. Sawada S, Takeda T, Kitano H, Takeuchi S, Kakigi A, Azuma H: Aquaporin-2 regulation by vasopressin in the rat inner ear. Neuroreport 2002; 13: 1127-1129.
8. Fukushima K, Takeda T, Kakigi A, Takeda S, Sawada S, Nishioka R, Azuma H, Taguchi T: Effects of lithium on endolymph homeostasis and experimentally induced endolymphatic hydrops. ORL J Otorhinolaryngol Relat Spec 2005; 67: 282-288.
9. Watanabe I: Ménière's disease. With special emphasis on epidemiology, diagnosis and prognosis. ORL 1980; 42: 20-45.
10. Moffat DA, Ballagh RH: Ménière's disease; in Booth JB (ed): Scott-Brown's Otolaryngology. Oxford, Butterworth-Heinemann, 1997, pp 1-50.
11. Futaki T, Kitahara M, Morimoto M: A comparison of the furosemide and glycerol tests for Ménière's disease: with special reference to the bilateral lesion. Acta Otolaryngol (Stockh) 1977; 83: 272-278.
12. Mizukoshi K, Watanabe Y, Ito M, Aso S, Kobayashi H, Shojaku H: The clinical significance of the furosemide VOR test for Ménière's disease; in Kaufman Arenberg I (eds): Inner Ear Surgery. Amsterdam, Kugler, 1991, pp 161-165.
13. Kimura H, Aso S, Watanabe Y: Prediction of progression from atypical to definite Ménière's disease using electrocochleography and glycerol and furosemide tests. Acta Otolaryngol 2003; 123: 388-395.
14. Mori N, Asai A, Suizu Y, Ohta K, Matsunaga T: Comparison between electrocochleography and glycerol test in the diagnosis of Méniè re's disease. Scand Audiol 1985; 14: 209-213.
15. Ito M, Watanabe Y, Shojaku H, Kobayashi H, Aso S, Mizukoshi K: Furosemide VOR test for the detection of endolymphatic hydrops. Acta Otolaryngol Suppl (Stockh) 1993; 504: 55-57.
16. Takeda T, Sawada S, Takeda S, Kitano H, Suzuki M, Kakigi A, Takeuchi S: The effects of V 2 antagonist (OPC-31260) on endolymphatic hydrops. Hear Res 2003; 182: 9-18.
17. Takeda T, Takeda S, Kakigi A, Okada T, Nishioka R, Taguchi D: A comparison of dehydration effects of V 2 antagonist (OPC- 31260) on the inner ear between systemic and round window applications. Hear Res 2006; 218: 89-97